Abstract:Objective To observe the impact of different concentration of ropivacaine on patients undergoing epiglottic cyst removal. Methods A total of 60 patients who received epiglottic cyst removal in our hospital from September 2019 to November 2019 were included and randomly divided into control group (Group A), normal-dose group (Group B) and low-dose group (Group C). Group A received general anesthesia, Group B received ultrasoundguided bilateral superior laryngeal nerve block with 0.5% ropivacaine hydrochloride combined with general anesthesia, while Group C received general anesthesia and was administrated with 0.25% ropivacaine hydrochloride to achieve ultrasound-guided bilateral superior laryngeal nerve block. Results The demographic characteristics of the three groups showed no significant difference (P > 0.05). The infusion rates of propofol and remifentanil before laryngoscope placement (T0) and when the BIS value was 40 to 60 (T2) in Group B and C were lower than those in Group A (P < 0.05). The HR, MAP and BIS maximum fluctuation at T0 and the moment of laryngoscope placement (T1) in Group B and C were lower than those in Group A (P < 0.05). The VAS scores at the moment and 6 h after extubation in Group B and C were significantly lower than those of Group A (P < 0.05). The incidence of dyspnea and dysphagia after extubation in Group C was lower than those in Group B (P < 0.05), while the satisfaction of Group C was higher than that in Group B and A (P < 0.05). Conclusions To achieve the superior laryngeal nerve block with 0.25% ropivacaine could better keep hemodynamic stablity, effectively relieve postoperative pain in patients with epiglottic cyst, reduce the incidence of complications, and achieve comfortable medical treatment and rapid recovery.